• Healthcare 150
  • Posts
  • Artificial Intelligence Is Becoming Healthcare's Next Infrastructure Layer

Artificial Intelligence Is Becoming Healthcare's Next Infrastructure Layer

Healthcare has reached an AI inflection point. After three years dominated by experimentation, the industry is shifting from exploring what Generative AI can do to determining where it can deliver measurable economic value.

July 06, 2026

Healthcare has reached an AI inflection point. After three years dominated by experimentation, the industry is shifting from exploring what Generative AI can do to determining where it can deliver measurable economic value. The question is no longer whether AI will transform healthcare, but which organizations will capture that value.

Few industries have more to gain. Healthcare continues to face mounting workforce shortages, rising administrative costs, declining R&D productivity, and increasing pressure to improve outcomes while controlling spending. These structural challenges have transformed AI from an emerging technology into a strategic necessity.

The first wave of adoption focused on clinical copilots—tools that assist physicians with documentation, decision support, and administrative tasks. The next wave will be defined by autonomous workflows, where AI agents coordinate complex operational processes across providers, payers, MedTech, and life sciences.

For investors, this shift marks an important change. As foundation models become increasingly commoditized, competitive advantage will move beyond the models themselves. Value is likely to accrue to organizations that own proprietary healthcare data, integrate deeply into clinical workflows, and build the infrastructure needed to deploy AI safely at scale.

Healthcare is entering a new phase of artificial intelligence. The era of experimentation is ending. The era of operational transformation has begun.

The Industry Has Reached an AI Inflection Point

For decades, healthcare has lagged behind other industries in adopting transformative technologies. Regulatory complexity, fragmented data, and legacy IT systems have made innovation slow, expensive, and difficult to scale. While sectors like finance and retail rapidly embraced automation, healthcare often struggled just to digitize existing workflows.

Artificial intelligence initially appeared destined to follow the same path.

When Generative AI entered the spotlight in late 2022, enthusiasm quickly outpaced execution. Health systems launched pilots, pharmaceutical companies explored foundation models, and nearly every healthcare technology vendor announced AI-powered products. Yet most deployments remained limited to proof-of-concept initiatives, constrained by governance concerns, clinical risk, and uncertain return on investment.

Two years later, the conversation has fundamentally changed.

Healthcare organizations are no longer asking whether AI belongs inside the enterprise. Instead, they are determining which applications generate measurable value, where AI should be deployed first, and how it can be embedded into everyday clinical and operational workflows. The industry's focus has shifted from experimentation to execution.

That transition is reflected in how different segments are prioritizing AI capabilities.

Figure 1. AI priorities are beginning to diverge across the healthcare ecosystem.

Rather than converging around a single technology, each segment is pursuing AI according to its own economic priorities. Pharmaceutical and biotechnology companies are investing heavily in predictive analytics and data science to accelerate drug discovery. Providers remain focused on generative AI to reduce administrative burden and improve clinician productivity. Meanwhile, digital health companies are emerging as early adopters of agentic AI, signaling a shift from AI systems that assist humans toward systems capable of executing increasingly complex workflows.

For investors, this marks an important inflection point. The competitive advantage is no longer determined by access to large language models—those are rapidly becoming commoditized. Instead, value is shifting toward organizations that can integrate AI into clinical workflows, leverage proprietary healthcare data, and deploy the infrastructure needed to scale AI safely across the enterprise.

Healthcare has moved beyond the question of whether AI will transform the industry. The next phase will be defined by how organizations turn AI into a durable operational advantage.

From AI Experimentation to Enterprise Value

If the first wave of healthcare AI was defined by experimentation, the second is being defined by economics.

For nearly two years, healthcare organizations invested heavily in pilots, testing everything from ambient documentation to clinical decision support. While these initiatives demonstrated AI's technical capabilities, many struggled to answer a more important question: Would AI generate measurable business value?

That question is becoming easier to answer.

McKinsey estimates that Generative AI could unlock $60–110 billion in annual productivity gains across the healthcare sector, driven largely by administrative automation, clinical documentation, revenue cycle management, and accelerated drug discovery. Rather than creating entirely new business models, AI is improving the economics of existing ones by reducing friction across some of healthcare's most labor-intensive processes.

Early deployments suggest this value is already materializing.

Healthcare executives are increasingly reporting that AI initiatives are delivering tangible financial benefits through both revenue growth and cost reduction. As organizations move beyond isolated proof-of-concept projects, AI is becoming an operational investment measured by the same financial metrics as any other enterprise technology: productivity, margin expansion, and return on investment.

Figure 2. AI is increasingly translating into measurable financial performance.

The data highlights an important shift. Compared with 2024, a significantly larger share of healthcare organizations now report that AI is contributing more than 10% to annual revenue growth while simultaneously generating meaningful cost savings. Just as important, the proportion of executives reporting no measurable impact continues to decline, suggesting that AI deployments are moving beyond experimentation and beginning to scale across the enterprise.

This distinction matters because healthcare's greatest AI opportunity has never been workforce replacement—it has been workforce augmentation. Every hour removed from documentation, prior authorization, coding, or administrative coordination creates additional clinical capacity without requiring additional staff. In an industry facing persistent labor shortages and mounting cost pressures, even incremental productivity improvements can translate into meaningful financial outcomes.

For investors, this represents the industry's true AI inflection point. The debate is no longer centered on what AI is capable of achieving, but on which organizations can operationalize it at scale. As implementation becomes the primary differentiator, competitive advantage will increasingly belong to companies capable of embedding AI into mission-critical workflows rather than simply adding AI features to existing products.

The winners of the next decade will likely be defined not by the sophistication of their models, but by the consistency of the economic value they create.

From Clinical Copilots to Autonomous Workflows

The first generation of healthcare AI focused on helping people work more efficiently. Clinical copilots summarized patient records, generated documentation, suggested diagnoses, and automated routine administrative tasks. Their objective was simple: improve individual productivity while keeping clinicians firmly in control.

That approach proved successful because it addressed one of healthcare's biggest constraints—not a lack of medical knowledge, but a lack of time.

Yet productivity gains at the individual level represent only the first stage of AI adoption.

Healthcare organizations are now beginning to shift their attention toward a more ambitious objective: automating entire workflows rather than isolated tasks. Instead of using AI to draft a clinical note, organizations are exploring systems capable of coordinating documentation, coding, scheduling, prior authorization, and follow-up care as part of a single connected process.

This transition marks the emergence of multiagent workflows.

Unlike traditional copilots, which support a single user during a specific task, multiagent systems combine specialized AI agents that collaborate to execute increasingly complex operational processes. One agent may summarize patient records, another verify insurance eligibility, another schedule appointments, and another generate reimbursement documentation—all working together with minimal human intervention.

Although adoption remains in its early stages, healthcare leaders are already moving beyond standalone AI assistants toward workflow automation.

Figure 3. Healthcare organizations are beginning to adopt multiagent AI workflows.

The adoption patterns reveal an industry still taking a measured approach. Most organizations continue to deploy AI through focused, function-specific solutions, while only a third report implementing end-to-end workflow automation. Healthcare services and technology companies appear to be moving fastest, reflecting their greater digital maturity and ability to redesign operational processes more rapidly than traditional providers.

For investors, the implications extend well beyond productivity software.

Clinical copilots may improve how individual employees work. Multiagent systems have the potential to redefine how healthcare organizations operate. As AI evolves from assisting tasks to coordinating enterprise workflows, competitive advantage will increasingly depend on the underlying infrastructure that enables these systems to access data, communicate across platforms, and operate securely at scale.

And that is where the next battleground begins.

The Infrastructure Race

As AI capabilities mature, the competitive landscape is shifting once again.

For the past three years, healthcare organizations have focused on identifying high-value AI use cases and demonstrating measurable returns. The next challenge is fundamentally different: scaling those successes across the enterprise.

That requires far more than increasingly powerful models.

Unlike most industries, healthcare operates on fragmented data, highly regulated workflows, and mission-critical decisions where trust is essential. As AI moves from supporting individual tasks to orchestrating end-to-end workflows, the limiting factor is no longer model performance—it's the organization's ability to integrate AI into existing clinical and operational infrastructure.

Figure 4. Successful AI adoption depends more on organizational readiness than model capability.

The findings reinforce a broader shift across the industry. Healthcare leaders identify workforce training and technical infrastructure as the two most important enablers of successful AI adoption, ranking them above regulatory considerations and even data privacy. In other words, organizations are increasingly recognizing that AI transformation is as much an operational challenge as a technological one.

This has important implications for investors.

As foundation models become increasingly commoditized, sustainable competitive advantage is likely to accrue to organizations that own the infrastructure surrounding AI—trusted clinical data, interoperable platforms, workflow integration, cybersecurity, and governance. The winners will not necessarily be those with the most sophisticated algorithms, but those capable of deploying AI reliably across complex healthcare environments.

Healthcare's AI race is no longer about building smarter models.

It's about building smarter systems.

Investment Implications

Artificial intelligence is rapidly becoming a foundational layer of healthcare rather than a standalone technology. As adoption matures, the market is likely to reward companies that enable AI at scale—not just those that build AI applications.

In the near term, much of the value will continue to accrue to software vendors solving high-friction administrative problems such as clinical documentation, revenue cycle management, and workflow automation. These use cases have already demonstrated measurable ROI and offer the fastest path to enterprise adoption.

Over the longer term, however, the investment opportunity shifts further down the technology stack. As foundation models become increasingly commoditized, sustainable competitive advantages will be built around proprietary healthcare data, interoperability, secure infrastructure, and deep integration into clinical workflows. Organizations that become embedded in how healthcare is delivered—not simply how AI is developed—are likely to capture a disproportionate share of the industry's next wave of value creation.

For investors, the key question is no longer who has the best AI model, but who owns the workflows where AI creates value.

Bottom Line

Healthcare is entering a new phase of artificial intelligence.

The first chapter was about proving that AI could work. The second is about proving that it can scale. Across providers, payers, MedTech, and life sciences, the conversation has shifted from experimentation to execution—from deploying copilots to redesigning workflows, and from building models to building infrastructure.

This evolution is redefining where competitive advantage will be created.

The companies most likely to lead the next decade will not necessarily develop the most advanced algorithms. They will be the ones that combine trusted data, seamless workflow integration, robust governance, and measurable operational impact into platforms that become indispensable to the delivery of care.

Healthcare's AI race is no longer about intelligence alone.

It's about infrastructure. And the organizations building it today will shape the future of healthcare tomorrow.

Sources

This Deep Dive synthesizes insights, data, and analysis from the following industry reports and research publications: